Unraveling aminoglycoside nephrotoxicity using animal models

Cross-Canada differences in early-stage breast cancer treatment and acute-care use.

Current oncology (Toronto, Ont.)·2019

ORE identifies extreme expression effects enriched for rare variants.

Bioinformatics (Oxford, England)·2019

First Report of White Mold (Sclerotinia sclerotiorum) on Soybean in Maine.

Plant disease·2019

The role of scientific evidence in decisions to adopt complex innovations in cancer care settings: a multiple case study in Nova Scotia, Canada.

Implementation science : IS·2019

Patterns of cancer centre follow-up care for survivors of breast, colorectal, gynecologic, and prostate cancer.

Current oncology (Toronto, Ont.)·2017

Cross-disciplinary research in cancer: an opportunity to narrow the knowledge-practice gap.

Current oncology (Toronto, Ont.)·2013

Model-Informed Decision Making from Drug Discovery to Reimbursement: A Roadmap for Clinical Pharmacology in Value-Based Healthcare.

Journal of clinical pharmacology·2026

PBPK Models for Fetal Drug Exposure: A Critical Assessment of Current Approaches and Regulatory Readiness.

Journal of clinical pharmacology·2026

Clinical Pharmacology in China: Seven Decades of Progress in Discipline Development and Education.

Journal of clinical pharmacology·2026

Semaglutide-Induced Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.

Journal of clinical pharmacology·2026

Safety, Pharmacokinetics, Food effect, and Pharmacodynamics of AJM347, a Selective α4β7 Integrin Antagonist: A First-in-Human Single- and Multiple-Ascending Dose Study in Healthy Male Volunteers.

Journal of clinical pharmacology·2026

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.

Journal of clinical pharmacology·2026

Patient-Derived Organoid and Single-Cell Multiomics Reveal Evolution Driven by CEACAM6/KRT19-Mediated Heterogeneity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Primary Cardiac Paraganglioma Management and Resection With Rare Recurrent Metastasis.

JACC. Case reports·2026

Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes.

Dalton transactions (Cambridge, England : 2003)·2026

Metal-Phenolic Networks: Emerging Nanoarchitectures for Cancer Therapy.

Angewandte Chemie (International ed. in English)·2026

Intracellular Delivery of Antibody-Based Therapeutics for Targeted Oncogenic c-Myc Degradation in Mammalian Cells and Mice.

Angewandte Chemie (International ed. in English)·2026

Tripping the switch: p38 inhibition unlocks venetoclax and inotuzumab ozogamicin synergy.

Haematologica·2026

Related Experiment Videos

Unraveling aminoglycoside nephrotoxicity using animal models

Related Concept Videos

Cross-Canada differences in early-stage breast cancer treatment and acute-care use.

ORE identifies extreme expression effects enriched for rare variants.

First Report of White Mold (Sclerotinia sclerotiorum) on Soybean in Maine.

The role of scientific evidence in decisions to adopt complex innovations in cancer care settings: a multiple case study in Nova Scotia, Canada.

Patterns of cancer centre follow-up care for survivors of breast, colorectal, gynecologic, and prostate cancer.

Cross-disciplinary research in cancer: an opportunity to narrow the knowledge-practice gap.

Model-Informed Decision Making from Drug Discovery to Reimbursement: A Roadmap for Clinical Pharmacology in Value-Based Healthcare.

PBPK Models for Fetal Drug Exposure: A Critical Assessment of Current Approaches and Regulatory Readiness.

Clinical Pharmacology in China: Seven Decades of Progress in Discipline Development and Education.

Semaglutide-Induced Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.

Safety, Pharmacokinetics, Food effect, and Pharmacodynamics of AJM347, a Selective α4β7 Integrin Antagonist: A First-in-Human Single- and Multiple-Ascending Dose Study in Healthy Male Volunteers.

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.

Patient-Derived Organoid and Single-Cell Multiomics Reveal Evolution Driven by CEACAM6/KRT19-Mediated Heterogeneity.

Primary Cardiac Paraganglioma Management and Resection With Rare Recurrent Metastasis.

Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes.

Metal-Phenolic Networks: Emerging Nanoarchitectures for Cancer Therapy.

Intracellular Delivery of Antibody-Based Therapeutics for Targeted Oncogenic c-Myc Degradation in Mammalian Cells and Mice.

Tripping the switch: p38 inhibition unlocks venetoclax and inotuzumab ozogamicin synergy.

Related Experiment Videos

Unraveling aminoglycoside nephrotoxicity using animal models

Related Concept Videos

Related Articles